Reversal of acute allograft rejection using immunotoxin.
Knechtle
S J
SJ
Department of Surgery, University of Wisconsin, Madison, USA.
Fechner
J H
JH
Stavrou
S
S
Neville
D M
DM
Dong
Y
Y
Hong
X
X
Tsuchida
M
M
Hamawy
M M
MM
D000208:Acute Disease; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001426:Bacterial Proteins / Q000627:therapeutic use*; D017252:CD3 Complex / Q000276:immunology; D004167:Diphtheria Toxin / Q000627:therapeutic use*; D006084:Graft Rejection / Q000188:drug therapy*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000922:Immunotoxins / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008212:Lymphocyte Depletion; D008253:Macaca mulatta; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D016038:Skin Transplantation / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D001426:Bacterial Proteins; D017252:CD3 Complex; C053395:CRM9 protein, bacteria; D004167:Diphtheria Toxin; C114317:FN18-CRM9; D007166:Immunosuppressive Agents; D000922:Immunotoxins; D011993:Recombinant Fusion Proteins; D009173:Mycophenolic Acid